Published in CMAJ on July 03, 2007
Ethnic disparities in accessing treatment for depression and substance use disorders in an integrated health plan. Int J Psychiatry Med (2010) 1.02
Impact of binge alcohol on mortality among people who inject drugs. Addict Behav Rep (2015) 0.95
Inability to access addiction treatment and risk of HIV infection among injection drug users recruited from a supervised injection facility. J Public Health (Oxf) (2009) 0.87
The impact of drug use patterns on mortality among polysubstance users in a Canadian setting: a prospective cohort study. BMC Public Health (2014) 0.86
Methadone use among HIV-positive injection drug users in a Canadian setting. J Subst Abuse Treat (2010) 0.80
Offending, custody and opioid substitution therapy treatment utilisation among opioid-dependent people in contact with the criminal justice system: comparison of Indigenous and non-Indigenous Australians. BMC Public Health (2014) 0.75
Impact of a methadone maintenance program on an Aboriginal community: a qualitative study. CMAJ Open (2016) 0.75
Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS (1997) 9.08
Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet (1999) 8.91
Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective. Arch Intern Med (2001) 4.68
Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. CMAJ (2003) 4.38
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev (2003) 2.45
Methadone maintenance at different dosages for opioid dependence. Cochrane Database Syst Rev (2003) 2.44
Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. CMAJ (2006) 2.06
Markers of access to and quality of primary care for aboriginal people in Ontario, Canada. Am J Public Health (2003) 1.85
In search of a healing place: Aboriginal women in Vancouver's Downtown Eastside. Soc Sci Med (2003) 1.78
"Nobody gives a damn if I live or die": violence, drugs, and street-level prostitution in inner-city Hartford, Connecticut. Med Anthropol (2003) 1.72
Recent incarceration independently associated with syringe sharing by injection drug users. Public Health Rep (2005) 1.53
Slower uptake of HIV antiretroviral therapy among Aboriginal injection drug users. J Infect (2005) 1.21
The quest to improve Aboriginal health. CMAJ (2006) 1.21
Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database Syst Rev (2004) 1.02
Access and utilization of health services by British Columbia's rural Aboriginal population. Int J Health Care Qual Assur Inc Leadersh Health Serv (2005) 0.99
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet (2010) 12.82
The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet (2006) 7.17
Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ (2009) 6.03
Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS (2003) 5.53
Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver. CMAJ (2003) 4.38
Social and structural violence and power relations in mitigating HIV risk of drug-using women in survival sex work. Soc Sci Med (2007) 4.14
Structural and environmental barriers to condom use negotiation with clients among female sex workers: implications for HIV-prevention strategies and policy. Am J Public Health (2009) 3.85
Safer injection facility use and syringe sharing in injection drug users. Lancet (2005) 3.85
Global landscape of HIV-human protein complexes. Nature (2011) 3.70
Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. CMAJ (2002) 3.70
Changes in Canadian heroin supply coinciding with the Australian heroin shortage. Addiction (2006) 3.65
Evaluating methamphetamine use and risks of injection initiation among street youth: the ARYS study. Harm Reduct J (2006) 3.49
Rationale for evaluating North America's first medically supervised safer-injecting facility. Lancet Infect Dis (2004) 3.20
Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users. CMAJ (2003) 3.19
Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study. Lancet (2011) 3.14
The Canadian government's treatment of scientific process and evidence: inside the evaluation of North America's first supervised injecting facility. Int J Drug Policy (2008) 3.05
Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology (2002) 2.99
Highly active antiretroviral therapy and survival in HIV-infected injection drug users. JAMA (2008) 2.77
Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. AIDS (2002) 2.74
Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users. Addiction (2010) 2.65
Displacement of Canada's largest public illicit drug market in response to a police crackdown. CMAJ (2004) 2.63
Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. CMAJ (2004) 2.62
The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years. AIDS (2007) 2.58
Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users. J Infect Dis (2011) 2.55
Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug Alcohol Depend (2006) 2.53
Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugs. CMAJ (2009) 2.51
The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART. AIDS (2007) 2.39
The impact of a police presence on access to needle exchange programs. J Acquir Immune Defic Syndr (2003) 2.37
Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alcohol Depend (2006) 2.33
The association between food insecurity and mortality among HIV-infected individuals on HAART. J Acquir Immune Defic Syndr (2009) 2.31
Hepatitis C virus reinfection in injection drug users. Hepatology (2006) 2.25
Binge drug use independently predicts HIV seroconversion among injection drug users: implications for public health strategies. Subst Use Misuse (2006) 2.22
A review of barriers and facilitators of HIV treatment among injection drug users. AIDS (2008) 2.21
Impact of supply-side policies for control of illicit drugs in the face of the AIDS and overdose epidemics: investigation of a massive heroin seizure. CMAJ (2003) 2.18
Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes. Antivir Ther (2004) 2.14
A call for evidence-based medical treatment of opioid dependence in the United States and Canada. Health Aff (Millwood) (2013) 2.09
Potential use of safer injecting facilities among injection drug users in Vancouver's Downtown Eastside. CMAJ (2003) 2.08
Homelessness and unstable housing associated with an increased risk of HIV and STI transmission among street-involved youth. Health Place (2009) 2.07
Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. CMAJ (2006) 2.06
Public injecting and the need for 'safer environment interventions' in the reduction of drug-related harm. Addiction (2006) 2.06
Expanding access to HAART: a cost-effective approach for treating and preventing HIV. AIDS (2010) 2.04
Community-based HIV prevention research among substance-using women in survival sex work: the Maka Project Partnership. Harm Reduct J (2007) 2.02
Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes. Am J Public Health (2010) 2.00
Income generating activities of people who inject drugs. Drug Alcohol Depend (2007) 1.95
Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy. AIDS (2009) 1.90
Effects of police confiscation of illicit drugs and syringes among injection drug users in Vancouver. Int J Drug Policy (2007) 1.90
Unstable housing, associated risk behaviour, and increased risk for HIV infection among injection drug users. Health Place (2004) 1.90
The direct costs of HIV/AIDS care. Lancet Infect Dis (2006) 1.87
Public injection settings in Vancouver: physical environment, social context and risk. Int J Drug Policy (2007) 1.86
Attendance at supervised injecting facilities and use of detoxification services. N Engl J Med (2006) 1.83
Police and public health partnerships: evidence from the evaluation of Vancouver's supervised injection facility. Subst Abuse Treat Prev Policy (2008) 1.83
Rate of detoxification service use and its impact among a cohort of supervised injecting facility users. Addiction (2007) 1.81
Social and environmental predictors of plasma HIV RNA rebound among injection drug users treated with antiretroviral therapy. J Acquir Immune Defic Syndr (2012) 1.80
Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users. Harm Reduct J (2004) 1.77
Circumstances of first crystal methamphetamine use and initiation of injection drug use among high-risk youth. Drug Alcohol Rev (2008) 1.77
Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modern antiretroviral therapy. J Infect Dis (2003) 1.77
Impact of HAART and injection drug use on life expectancy of two HIV-positive cohorts in British Columbia. AIDS (2006) 1.72
Burden of HIV infection among aboriginal injection drug users in Vancouver, British Columbia. Am J Public Health (2008) 1.71
Females experiencing sexual and drug vulnerabilities are at elevated risk for HIV infection among youth who use injection drugs. J Acquir Immune Defic Syndr (2002) 1.69
Baseline self-perceived risk of HIV infection independently predicts the rate of HIV seroconversion in a prospective cohort of injection drug users. Int J Epidemiol (2004) 1.67
Associations between childhood maltreatment and sex work in a cohort of drug-using youth. Soc Sci Med (2007) 1.66
Illicit drug addiction, infectious disease spread, and the need for an evidence-based response. Lancet Infect Dis (2008) 1.66
Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: implications for HIV prevention. Can J Public Health (2003) 1.66